Seamus Fernandez
Stock Analyst at Guggenheim
(4.95)
# 128
Out of 4,504 analysts
410
Total ratings
65.6%
Success rate
30.8%
Average return
Main Sectors:
Stocks Rated by Seamus Fernandez
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMY Bristol-Myers Squibb Company | Maintained: Buy | $72 | $57.58 | +25.04% | 49 | Jul 9, 2026 | |
| SNY Sanofi | Maintained: Hold | n/a | $43.50 | - | 13 | Jul 9, 2026 | |
| LON: AZN AstraZeneca PLC | Reiterated: Buy | 16,500p → 16,200p | $12,834.00 | +26.23% | 20 | Jul 9, 2026 | |
| SEPN Septerna | Reiterated: Buy | $52 → $45 | $35.93 | +25.24% | 2 | Jul 1, 2026 | |
| AMLX Amylyx Pharmaceuticals | Reiterated: Buy | $30 → $40 | $17.77 | +125.10% | 9 | Jun 26, 2026 | |
| GENB Generate Biomedicines | Reiterated: Buy | $30 | $14.33 | +109.42% | 3 | Jun 24, 2026 | |
| APGE Apogee Therapeutics | Downgraded: Hold | n/a | $133.65 | - | 12 | Jun 23, 2026 | |
| TENX Tenax Therapeutics | Maintained: Buy | $34 → $40 | $17.55 | +127.92% | 6 | Jun 22, 2026 | |
| RYTM Rhythm Pharmaceuticals | Reiterated: Buy | $143 | $108.40 | +31.92% | 13 | Jun 15, 2026 | |
| MBX MBX Biosciences | Reiterated: Buy | $88 | $61.05 | +44.14% | 14 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $116 | $58.21 | +99.28% | 12 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $4.30 | +155.81% | 6 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $27.74 | +26.17% | 13 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $28.38 | +69.13% | 8 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.97 | - | 10 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.58 | +115.05% | 4 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 | $53.36 | +162.37% | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,163 → $1,235 | $1,188.58 | +3.91% | 61 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $25 | $7.37 | +239.21% | 4 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €110.00 → €101.00 | $76.23 | +32.49% | 10 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $49.48 | n/a | 10 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.05 | n/a | 12 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 1,013 → kr 798.00 | $321.58 | n/a | 4 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $52.78 | n/a | 5 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1,961.50 | n/a | 5 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 → $130 | $123.54 | n/a | 36 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 → $83 | $20.49 | n/a | 5 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.7834 | n/a | 2 | Dec 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $139.70 | n/a | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $124.28 | n/a | 4 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $154.05 | n/a | 16 | Oct 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $5.28 | n/a | 1 | Oct 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.74 | n/a | 2 | Sep 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $37 | $24.17 | n/a | 16 | Sep 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $108 | $14.35 | n/a | 1 | Aug 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $7.61 | n/a | 3 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $298.76 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $363.39 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $664.52 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $256.98 | n/a | 2 | Jun 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $56 | $41.23 | n/a | 5 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $39.11 | n/a | 1 | Mar 7, 2016 |
Bristol-Myers Squibb Company
Jul 9, 2026
Maintained: Buy
Price Target: $72
Current: $57.58
Upside: +25.04%
Sanofi
Jul 9, 2026
Maintained: Hold
Price Target: n/a
Current: $43.50
Upside: -
AstraZeneca PLC
Jul 9, 2026
Reiterated: Buy
Price Target: 16,500p → 16,200p
Current: $12,834.00
Upside: +26.23%
Septerna
Jul 1, 2026
Reiterated: Buy
Price Target: $52 → $45
Current: $35.93
Upside: +25.24%
Amylyx Pharmaceuticals
Jun 26, 2026
Reiterated: Buy
Price Target: $30 → $40
Current: $17.77
Upside: +125.10%
Generate Biomedicines
Jun 24, 2026
Reiterated: Buy
Price Target: $30
Current: $14.33
Upside: +109.42%
Apogee Therapeutics
Jun 23, 2026
Downgraded: Hold
Price Target: n/a
Current: $133.65
Upside: -
Tenax Therapeutics
Jun 22, 2026
Maintained: Buy
Price Target: $34 → $40
Current: $17.55
Upside: +127.92%
Rhythm Pharmaceuticals
Jun 15, 2026
Reiterated: Buy
Price Target: $143
Current: $108.40
Upside: +31.92%
MBX Biosciences
Jun 15, 2026
Reiterated: Buy
Price Target: $88
Current: $61.05
Upside: +44.14%
Jun 3, 2026
Maintained: Buy
Price Target: $116
Current: $58.21
Upside: +99.28%
May 27, 2026
Reiterated: Buy
Price Target: $11
Current: $4.30
Upside: +155.81%
May 26, 2026
Maintained: Buy
Price Target: $35
Current: $27.74
Upside: +26.17%
May 18, 2026
Maintained: Buy
Price Target: $48
Current: $28.38
Upside: +69.13%
May 11, 2026
Maintained: Hold
Price Target: n/a
Current: $6.97
Upside: -
May 11, 2026
Reiterated: Buy
Price Target: $12
Current: $5.58
Upside: +115.05%
May 7, 2026
Maintained: Buy
Price Target: $140
Current: $53.36
Upside: +162.37%
May 5, 2026
Maintained: Buy
Price Target: $1,163 → $1,235
Current: $1,188.58
Upside: +3.91%
Apr 29, 2026
Reiterated: Buy
Price Target: $27 → $25
Current: $7.37
Upside: +239.21%
Oct 8, 2025
Maintained: Buy
Price Target: €110.00 → €101.00
Current: $76.23
Upside: +32.49%
Apr 17, 2025
Downgraded: Hold
Price Target: n/a
Current: $49.48
Upside: n/a
Apr 3, 2025
Rated: Hold
Price Target: n/a
Current: $3.05
Upside: n/a
Jan 17, 2025
Maintained: Buy
Price Target: kr 1,013 → kr 798.00
Current: $321.58
Upside: n/a
Oct 31, 2024
Downgraded: Hold
Price Target: n/a
Current: $52.78
Upside: n/a
Oct 31, 2024
Downgraded: Hold
Price Target: n/a
Current: $1,961.50
Upside: n/a
Jan 29, 2024
Maintained: Buy
Price Target: $125 → $130
Current: $123.54
Upside: n/a
Oct 14, 2022
Maintained: Buy
Price Target: $250 → $83
Current: $20.49
Upside: n/a
Dec 15, 2021
Downgraded: Hold
Price Target: n/a
Current: $0.7834
Upside: n/a
Dec 7, 2021
Downgraded: Hold
Price Target: n/a
Current: $139.70
Upside: n/a
Feb 25, 2020
Downgraded: Hold
Price Target: n/a
Current: $124.28
Upside: n/a
Oct 8, 2018
Initiated Coverage: Hold
Price Target: n/a
Current: $154.05
Upside: n/a
Oct 17, 2017
Initiated Coverage: Buy
Price Target: $13
Current: $5.28
Upside: n/a
Sep 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $3.74
Upside: n/a
Sep 8, 2016
Maintained: Hold
Price Target: $37
Current: $24.17
Upside: n/a
Aug 24, 2016
Reiterated: Buy
Price Target: $108
Current: $14.35
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $52
Current: $7.61
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $298.76
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: n/a
Current: $363.39
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $664.52
Upside: n/a
Jun 14, 2016
Maintained: Buy
Price Target: $125
Current: $256.98
Upside: n/a
Jun 13, 2016
Reiterated: Hold
Price Target: $56
Current: $41.23
Upside: n/a
Mar 7, 2016
Downgraded: Hold
Price Target: $4
Current: $39.11
Upside: n/a